• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢型冠状动脉血流现象中 PPAR-α/γ 和 UCP1/2 的表达水平;一项病例对照研究的结果。

The expression levels of PPAR-α/γ and UCP1/2 on the slow coronary flow phenomenon; results from a case-control study.

机构信息

Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, 5166615573, Iran.

Students Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Mol Biol Rep. 2023 Sep;50(9):7527-7533. doi: 10.1007/s11033-023-08668-y. Epub 2023 Jul 27.

DOI:10.1007/s11033-023-08668-y
PMID:37501045
Abstract

PURPOSE

The slow coronary flow (SCF) phenomenon is considered a coronary artery disorder. Because of the critical function of peroxisome proliferator-activated receptors (PPARs) in regulating the oxidative stress and inflammatory reactions in cardiovascular disease, The aim of the current study was to investigate the expression of the genes for uncoupling proteins 1 and 2 (UCP1 and UCP2), peroxisome proliferator-activated receptors and (PPAR- PPAR-), and PPAR- in SCF patients.

METHODS

In this case-control study, coronary angiography examination was used to analyze 35 individuals with SCF and 35 subjects with normal coronary flow (NCF). SCF was diagnosed using the TIMI (thrombolysis in myocardial infarction frame count) method. The SCF phenomenon is thought to be the TIMI > 27. In the peripheral blood mononuclear cells (PBMCs), the messenger ribonucleic acid (mRNA) expression levels of the PPAR-, PPAR-, UCP1, and UCP2 genes were evaluated.

RESULTS

UCP1 and UCP2 expression levels were significantly higher in the SCF group compared to the NCF group (P = 0.034 and P0.001, respectively). The PPAR- and PPAR- levels were found to be significantly lower in the SCF group compared to the NCF group (P = 0.015, P0.001, respectively). According to the results of the logistic regression analysis, high UCP1 and UCP2 levels and low PPAR- and PPAR- levels are each independent predictors of the SCF phenomenon.

CONCLUSION

This research provided evidence about the potential role of PPAR-α, PPAR-γ, UCP1, and UCP2 as biomarkers in SCF. More investigations are suggested to assess the functions of these factors in SCF patients mechanistically.

摘要

目的

慢血流(SCF)现象被认为是一种冠状动脉疾病。由于过氧化物酶体增殖物激活受体(PPARs)在调节心血管疾病中的氧化应激和炎症反应方面具有重要作用,本研究旨在探讨解偶联蛋白 1 和 2(UCP1 和 UCP2)、过氧化物酶体增殖物激活受体和(PPAR-γ、PPAR-δ)以及 PPAR-γ 的基因在 SCF 患者中的表达。

方法

在这项病例对照研究中,我们使用冠状动脉造影检查分析了 35 名 SCF 患者和 35 名正常冠状动脉血流(NCF)患者。SCF 采用 TIMI(心肌梗死溶栓帧数)法诊断。SCF 现象被认为是 TIMI>27。在外周血单核细胞(PBMCs)中,评估了 PPAR-γ、PPAR-δ、UCP1 和 UCP2 基因的信使核糖核酸(mRNA)表达水平。

结果

与 NCF 组相比,SCF 组的 UCP1 和 UCP2 表达水平显著升高(P=0.034 和 P<0.001)。与 NCF 组相比,SCF 组的 PPAR-γ 和 PPAR-δ 水平显著降低(P=0.015、P<0.001)。根据逻辑回归分析的结果,高 UCP1 和 UCP2 水平以及低 PPAR-γ 和 PPAR-δ 水平均是 SCF 现象的独立预测因子。

结论

本研究提供了证据表明 PPAR-α、PPAR-γ、UCP1 和 UCP2 作为 SCF 的潜在生物标志物。建议进行更多的研究来评估这些因素在 SCF 患者中的作用机制。

相似文献

1
The expression levels of PPAR-α/γ and UCP1/2 on the slow coronary flow phenomenon; results from a case-control study.慢型冠状动脉血流现象中 PPAR-α/γ 和 UCP1/2 的表达水平;一项病例对照研究的结果。
Mol Biol Rep. 2023 Sep;50(9):7527-7533. doi: 10.1007/s11033-023-08668-y. Epub 2023 Jul 27.
2
Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon.血浆同型半胱氨酸与甲状腺激素浓度在冠状动脉血流缓慢现象发病机制中的相互作用。
Cardiology. 2007;108(3):186-92. doi: 10.1159/000096687. Epub 2006 Nov 3.
3
A novel inflammatory signaling pathway in patients with slow coronary flow: NF-κB/IL-1β/nitric oxide.一种新的炎症信号通路在慢血流患者中:NF-κB/IL-1β/一氧化氮。
Cytokine. 2021 Jul;143:155511. doi: 10.1016/j.cyto.2021.155511. Epub 2021 Apr 8.
4
Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.奥利司他在新诊断为非酒精性脂肪性肝病的肥胖患者中的补充作用:对代谢参数、人体测量指数以及 PPAR-α、UCP1 和 UCP2 基因表达的影响。
Pharmacol Res. 2020 Jun;156:104770. doi: 10.1016/j.phrs.2020.104770. Epub 2020 Mar 23.
5
The role of adrenergic activity in slow coronary flow and its relationship to TIMI frame count.肾上腺素能活性在冠状动脉血流缓慢中的作用及其与心肌梗死溶栓治疗(TIMI)帧数的关系。
Angiology. 2007 Aug-Sep;58(4):393-400. doi: 10.1177/0003319707305118. Epub 2007 Jul 24.
6
The relationship between neutrophil gelatinase-associated lipocalin levels and the slow coronary flow phenomenon.中性粒细胞明胶酶相关脂质运载蛋白水平与冠状动脉血流缓慢现象之间的关系。
Coron Artery Dis. 2014 Sep;25(6):505-9. doi: 10.1097/MCA.0000000000000121.
7
[Can biomarkers help us to understand the pathogenesis of coronary slow flow? Endocan and omentin-I in slow coronary flow phenomenon].[生物标志物能帮助我们理解冠状动脉慢血流的发病机制吗?内脂素和网膜素-1与冠状动脉慢血流现象]
Turk Kardiyol Dern Ars. 2019 Jun;47(4):251-257. doi: 10.5543/tkda.2018.27708.
8
Inverse correlation between coronary and retinal blood flows in patients with normal coronary arteries and slow coronary blood flow.在正常冠状动脉和慢血流患者中,冠状动脉血流和视网膜血流呈负相关。
Atherosclerosis. 2014 Jan;232(1):149-54. doi: 10.1016/j.atherosclerosis.2013.10.033. Epub 2013 Nov 12.
9
Clinical and coronary angiographic characteristics of patients with coronary slow flow.冠状动脉慢血流患者的临床及冠状动脉造影特征
Acta Cardiol. 2008 Oct;63(5):579-84. doi: 10.2143/AC.63.5.2033224.
10
Slow coronary flow is associated with carotid artery dilatation.冠状动脉血流缓慢与颈动脉扩张有关。
Tohoku J Exp Med. 2006 May;209(1):41-8. doi: 10.1620/tjem.209.41.

本文引用的文献

1
Epicardial Adipose Tissue Hyperinflammation Might be the Broken Thread in Coronary Artery Ectasia Pathogenesis.心外膜脂肪组织过度炎症可能是冠状动脉扩张症发病机制中的断裂之丝。
Angiology. 2023 Jul;74(6):600-601. doi: 10.1177/00033197221139690. Epub 2022 Nov 10.
2
Echocardiographic Evaluation of Left and Right Ventricular Function in Patients with Coronary Slow Flow Syndrome: A Comparative Study.超声心动图评价冠状动脉慢血流综合征患者左、右心室功能:一项对比研究。
Curr Probl Cardiol. 2022 Sep;47(9):100925. doi: 10.1016/j.cpcardiol.2021.100925. Epub 2021 Jul 3.
3
A novel inflammatory signaling pathway in patients with slow coronary flow: NF-κB/IL-1β/nitric oxide.
一种新的炎症信号通路在慢血流患者中:NF-κB/IL-1β/一氧化氮。
Cytokine. 2021 Jul;143:155511. doi: 10.1016/j.cyto.2021.155511. Epub 2021 Apr 8.
4
Slow Coronary Flow: Pathophysiology, Clinical Implications, and Therapeutic Management.缓慢性冠状动脉血流:病理生理学、临床意义和治疗管理。
Angiology. 2021 Oct;72(9):808-818. doi: 10.1177/00033197211004390. Epub 2021 Mar 29.
5
Expression of NF-κB, IL-6, and IL-10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD-Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple-blind randomized controlled clinical trial.肥胖非酒精性脂肪性肝病患者中 NF-κB、IL-6 和 IL-10 基因的表达、身体成分和肝纤维化:奥利诺酰胺补充和热量限制的联合作用:一项三盲随机对照临床试验。
J Cell Physiol. 2021 Jan;236(1):417-426. doi: 10.1002/jcp.29870. Epub 2020 Jun 22.
6
The Association between Inflammatory Cytokines and miRNAs with Slow Coronary Flow Phenomenon.炎症细胞因子和微小RNA与冠状动脉血流缓慢现象之间的关联
Iran J Allergy Asthma Immunol. 2020 Feb 1;19(1):56-64. doi: 10.18502/ijaai.v19i1.2418.
7
Clinical Profile and Outcome in Patients with Coronary Slow Flow Phenomenon.冠状动脉慢血流现象患者的临床特征与预后
Cardiol Res Pract. 2019 May 7;2019:9168153. doi: 10.1155/2019/9168153. eCollection 2019.
8
Oxidative Stress in Metabolic Disorders and Drug-Induced Injury: The Potential Role of Nrf2 and PPARs Activators.代谢紊乱和药物性损伤中的氧化应激:Nrf2和PPARs激活剂的潜在作用
Oxid Med Cell Longev. 2017;2017:2508909. doi: 10.1155/2017/2508909. Epub 2017 Nov 19.
9
The role of PPARgamma in cardiovascular diseases.过氧化物酶体增殖物激活受体γ在心血管疾病中的作用。
Physiol Res. 2016 Oct 24;65(Suppl 3):S343-S363. doi: 10.33549/physiolres.933439.
10
Mitochondrial mechanisms of endothelial dysfunction.内皮功能障碍的线粒体机制
Pharmacol Rep. 2015 Aug;67(4):704-10. doi: 10.1016/j.pharep.2015.04.009. Epub 2015 May 2.